-
Your selected country is
United States
- Change country/language
Old Browser
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
LAMBDA-PE
Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Most B cells, with the exception of pre-B progenitors, pre B cells, and mature plasma cells, express immunoglobulin on
their surface. Each cell expresses only one light chain type (Kappa or Lambda). In normal peripheral blood and lymph
nodes, there is a mixture of Kappa positive and Lambda positive cells, with two-thirds of the cells expressing Kappa and
one-third expressing Lambda. Since lymphoid neoplasms are usually clonal expansions of a single cell, malignant cells
uniformly express the same Light Chain isotype. Neoplastic B cell lymphoprolipherative disorders can frequently be
suspected based on the demonstration of a marker predominance of cells expressing a single Light Chain type. The Lambda immunoglobulin Light Chain count is generally expressed as a percentage of B cells present in the sample
that can be determined by flow cytometry based on its positive expression of CD19.
No Citations are available for this Product
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.
Analyte Specific Reagent. Analytical and performance characteristics are not established.
Documents are subject to revision without notice. Please verify you have the correct revision of the document, and always refer back to BD's eIFU website for the latest and most up to date information.